The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

Scarlett Espinoza joined Life Time's 60XT challenge. With strength training, high protein diet, and walking she lost 14 ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Study Overview: Amgen Inc. is conducting a Phase 3 study titled ‘A Phase ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.